SELLAS Life Sciences Group, Inc. Research And Development Expense

Quick Answer

SELLAS Life Sciences Group, Inc. reported Research And Development Expense of $15.67 million for the year ending 2021.

  • SELLAS Life Sciences Group, Inc. showed an increase of +68.9% in Research And Development Expense from 2020 to 2021.
  • This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
  • XBRL data for this metric is available from 2010 to 2021 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2010 to 2021), SELLAS Life Sciences Group, Inc.'s Research And Development Expense has grown by 99.1%.
  • Historical annual values: Fiscal year 2021: $15.67 million | Fiscal year 2020: $9.28 million | Fiscal year 2019: $7.29 million | Fiscal year 2018: $8.77 million | Fiscal year 2017: $6.07 million | Fiscal year 2016: $11.40 million | Fiscal year 2012: $14.61 million | Fiscal year 2011: $3.85 million | Fiscal year 2010: $7.87 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: